ALDH2 and acute myeloid leukemia: Our comparison of elderly low-risk and younger low-risk AML patients suggest that ALDH2 levels, cytoskeletal modulation and altered transcriptional regulation are consistent with an effect of aging on leukemogenesis and chemosensitivity in human AML.